Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid

被引：0
|
作者：
Roger von Moos
Jean-Jacques Body
Blair Egerdie
Alison Stopeck
Janet E. Brown
Danail Damyanov
Lesley J. Fallowfield
Gavin Marx
Charles S. Cleeland
Donald L. Patrick
Felipe G. Palazzo
Yi Qian
Ada Braun
Karen Chung
机构：
[1] Kantonsspital Graubünden,Chu Brugmann
[2] Université Libre De Bruxelles,Arizona Cancer Center
[3] Urology Associates/Urologic Medical Research,Sussex Health Outcomes Research & Education in Cancer (SHORE
[4] University of Arizona,C)
[5] Cancer Research UK Experimental Cancer Medicine Centres,Sydney Adventist Hospital
[6] National Hospital for Treatment in Oncology,undefined
[7] University of Sussex,undefined
[8] University of Sydney,undefined
[9] University of Texas MD Anderson Cancer Center,undefined
[10] University of Washington,undefined
[11] CAIPO,undefined
[12] Amgen Inc.,undefined
来源：
Supportive Care in Cancer | 2013年 / 21卷
关键词：
Denosumab; Bone metastases; Pain; Solid tumours; Zoledronic acid;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3497 / 3507
页数：10
相关论文
共 50 条
  • [1] Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid
    von Moos, Roger
    Body, Jean-Jacques
    Egerdie, Blair
    Stopeck, Alison
    Brown, Janet E.
    Damyanov, Danail
    Fallowfield, Lesley J.
    Marx, Gavin
    Cleeland, Charles S.
    Patrick, Donald L.
    Palazzo, Felipe G.
    Qian, Yi
    Braun, Ada
    Chung, Karen
    [J]. SUPPORTIVE CARE IN CANCER, 2013, 21 (12) : 3497 - 3507
  • [2] Erratum to: Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid
    Roger von Moos
    Jean-Jacques Body
    Blair Egerdie
    Alison Stopeck
    Janet E. Brown
    Danail Damyanov
    Lesley J. Fallowfield
    Gavin Marx
    Charles S. Cleeland
    Donald L. Patrick
    Felipe G. Palazzo
    Yi Qian
    Ada Braun
    Karen Chung
    [J]. Supportive Care in Cancer, 2014, 22 : 2309 - 2310
  • [3] Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid (vol 21, pg 3497, 2013)
    von Moos, Roger
    Body, Jean-Jacques
    Egerdie, Blair
    Stopeck, Alison
    Brown, Janet E.
    Damyanov, Danail
    Fallowfield, Lesley J.
    Marx, Gavin
    Cleeland, Charles S.
    Patrick, Donald L.
    Palazzo, Felipe G.
    Qian, Yi
    Braun, Ada
    Chung, Karen
    [J]. SUPPORTIVE CARE IN CANCER, 2014, 22 (08) : 2309 - 2310
  • [4] Pain Outcomes in Patients With Advanced Breast Cancer and Bone Metastases Results From a Randomized, Double-Blind Study of Denosumab and Zoledronic Acid
    Cleeland, Charles S.
    Body, Jean-Jacques
    Stopeck, Alison
    von Moos, Roger
    Fallowfield, Lesley
    Mathias, Susan D.
    Patrick, Donald L.
    Clemons, Mark
    Tonkin, Katia
    Masuda, Norikazu
    Lipton, Allan
    de Boer, Richard
    Salvagni, Stefania
    Oliveira, Celia Tosello
    Qian, Yi
    Jiang, Qi
    Dansey, Roger
    Braun, Ada
    Chung, Karen
    [J]. CANCER, 2013, 119 (04) : 832 - 838
  • [5] Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
    Stopeck, Alison T.
    Lipton, Allan
    Body, Jean-Jacques
    Steger, Guenther G.
    Tonkin, Katia
    de Boer, Richard H.
    Lichinitser, Mikhail
    Fujiwara, Yasuhiro
    Yardley, Denise A.
    Viniegra, Maria
    Fan, Michelle
    Jiang, Qi
    Dansey, Roger
    Jun, Susie
    Braun, Ada
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (35) : 5132 - 5139
  • [6] A meta-analysis of results from two randomized, double-blind studies of denosumab versus zoledronic acid (ZA) for treatment of bone metastases
    Lipton, A.
    Stopeck, A.
    von Moos, R.
    Henry, D. H.
    Richardson, G. E.
    Rodriguez, G. I.
    Bourgeois, H. P.
    Ke, C.
    Jun, S.
    Dansey, R. D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] Denosumab versus zoledronic acid (ZA) for the treatment of bone metastases: An integrated analysis of results from 2 randomized, double-blind, phase 3 trials
    Lipton, A.
    Stopeck, A.
    von Moos, R.
    Henry, D.
    Richardson, G.
    Rodriguez, G.
    Bourgeois, H.
    Ke, C.
    Jun, S.
    Dansey, R.
    [J]. BONE, 2011, 48 (01) : S21 - S21
  • [8] Results From a Phase 3 Randomized, Double-Blind, Double-Dummy Clinical Trial Comparing Denosumab with Zoledronic Acid for the Management of Bone Metastases in Patients with Advanced Solid Tumors or Multiple Myeloma
    von Moos, Roger
    Henry, David
    Vadhan-Raj, Saroj
    Hungria, Vania
    Spencer, Andrew
    Hirsh, Vera
    Wang, Jianming
    Susie, Jun
    Howard, Yeh
    Dansey, Roger
    [J]. BONE, 2010, 46 : S44 - S44
  • [9] EVALUATING PAIN AND ANALGESIC USE IN PATIENTS WITH SOLID TUMOURS AND BONE METASTASES RECEIVING DENOSUMAB OR ZOLEDRONIC ACID (ZA) FROM 3 IDENTICALLY-DESIGNED, RANDOMISED, DOUBLE-BLIND, TRIALS
    Woodhead, Sally
    Mayer, Gisela
    Fitzpatrick, Gail
    Frey, Georgette
    Wigginton, Hannah
    Cleeland, Charles
    Braun, Ada
    Qian, Yi
    Chung, Karen
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 : 357 - 357
  • [10] DENOSUMAB VERSUS ZOLEDRONIC ACID FOR THE PREVENTION OF SKELETAL-RELATED EVENTS IN PATIENTS WITH BONE METASTASES SECONDARY TO SOLID TUMOURS: AN INTEGRATED ANALYSIS OF THREE PHASE 3 STUDIES
    Stopeck, A. T.
    Richardson, G.
    Siena, S.
    Lipton, A.
    Brown, J.
    Fizazi, K.
    Henry, D.
    Saad, F.
    Ke, C.
    Braun, A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 : S8 - S8
12345